Activation of mononuclear cells by interleukin-12: An in vivo study in chimpanzees

Journal of Clinical Immunology

Volumn 19, Issue 4, 1999, Pages 231-238

  Lauw, Fanny N ^a   Te Velde, Anje A ^a   Dekkers, Pascale E P ^a   Speelman, Peter ^a   Aerts, Johannes M F G ^a   Hack, C Erik ^b   Van Deventer, Sander J H ^a   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

Author keywords

Cellular activation; Interleukin 12; Mononuclear cells; Non human primates; Th1 Th2 balance

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 12; REGULATOR PROTEIN;

ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CHIMPANZEE; HYPOTHESIS; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; MONONUCLEAR CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REGULATOR GENE;

ANIMALS; BIOLOGICAL MARKERS; CYTOTOXICITY, IMMUNOLOGIC; GRANZYMES; HEXOSAMINIDASES; INTERLEUKIN-12; KILLER CELLS, NATURAL; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE COUNT; MONOCYTES; PAN TROGLODYTES; PHAGOCYTES; SERINE ENDOPEPTIDASES;

EID: 0032841639     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020520130792     Document Type: Article

References (49)

1. Trinchieri G: Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008-4027, 1994
2. Schiff DE, Rae J, Martin TR, Davis BH, Cumutte JT: Increased phagocyte Fc gammaRI expression and improved Fc gamma-receptor-mediated phagocytosis after in vivo recombinant human interferon-gamma treatment of normal human subjects. Blood 90:3187-3194, 1997
3. Seder RA, Kelsall BL, Jankovic D: Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. J Immunol 157:2745-2748, 1996
4. Trinchieri G: Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13:251-276, 1995
5. Locksley RM: Interleukin 12 in host defense against microbial pathogens. Proc Natl Acad Sci USA 90:5879-5880, 1993
6. Romani L, Puccetti P, Bistoni F: Interleukin-12 in infectious diseases. Clin Microbiol Rev 10:611-636, 1997
7. Cooper AM, Magram J, Ferrante J, Orme IM: Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 186:39-45, 1997
8. Mattner F, Di Padova K, Alber G: Interleukin-12 is indispensable for protective immunity against Leishmania major. Infect Immun 65:4378-83, 1997
9. Tripp CS, Gately MK, Hakimi J, Ling P, Unanue ER: Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma. J Immunol 152:1883-1887, 1994
10. Cooper AM, Roberts AD, Rhoades ER, Callahan JE, Getzy DM, Orme IM: The role of interleukin-12 in aquired immunity to Mycobacterium tuberculosis infection. Immunology 84:423-432, 1995
11. Flynn JL, Goldstein MM, Triebold KJ, Sypek J, Wolf S, and Bloom BR: IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol 155:2515-2524, 1995
12. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK: Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 177:1505-1509, 1993
13. Sypek JP, Chung CL, Mayor SE, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG: Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T helper type I immune response. J Exp Med 177:1797-1802, 1993
14. Wagner RD, Steinberg H, Brown JF, Czuprynski CJ: Recombinant interleukin-12 enhances resistance of mice to Listeria monocytogenes infection. Microbial Pathogenesis 17:175-186, 1994
15. Greenberger MJ, Kunkel SL, Stricter RM, Lukaacs NW, Bramson J, Gauldie J, Graham FL, Hitt M, Danforth JM, Standiford TJ: IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J Immunol 157:3006-3012, 1996
16. Hoffman SL, Crutcher JM, Puri SK, Ansari AA, Villinger F, Franke ED, Singh PP, Finkelman F, Gately MK, Dutta GP, Sedegah M: Sterile protection of monkeys against malaria after administration of interleukin-12. Nature Med 3:80-83, 1997
17. Lauw FN, Dekkers PEP, Te Velde AA, Speelman P, Levi M, Kurimoto M, Hack CE, Van Deventer SJH, Van der Poll T: Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees. J Infect Dis 179; 646-652, 1999
18. Spits H, Ijssel H, Terhorst C, de Vries JE: Establishment of human T lymphocyte clones highly cytotoxic for an EBV-transformed B cell line in serum-free medium: Isolation of clones that differ in phenotype and specificity. J Immunol 128:95-99, 1982
19. Quaranta V, Walker LE, Pellegrino MA, Ferrone S: Purification of immunologically functional subsets of human 1a-like antigens on a monoclonal antibody (Q5/13) immunoadsorbent. J Immunol 125: 1421-1425, 1980
20. Rabinowich H, Sedlmayr P, Herberman RB, Whiteside TL: Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells. Cell Immunol 135:454-470, 1991
21. Spaeny-Dekking EA, Hanna WL, Wolbink AM, Wever PC, Kummer AJ, Swaak AJG, Middeldorp JM, Huisman HG, Froelich CJ, Hack CE: Extracellular granzymes A and B in man: Detection of native species during CTL responses in vitro and in vivo. J Immunol 160:3610-3616, 1998
22. Renkema GH, Boot RG, Muijsers AO, Donker-Koopman WE, Aerts JM: Purification and characterization of human chitotriosidase, a novel member of the chitinase family of proteins. J Biol Chem 270:2198-2202, 1995
23. Bree AG, Schlerman FJ, Kaviani MD, Hastings RC, Hitz SL, Goldman SJ: Multiple effects on peripheral hematology following administration of recombinant human interleukin-12 to nonhuman primates. Biochem Biophys Res Commun 204:1150-1157, 1994
24. Kohl S, Sigaroudinia M, Charlebois ED, Jacobson MA: Interleukin-12 administered in vivo decreases human NK cell cytotoxicity and antibody-dependent cellular cytotoxicity to human immunodeficiency virus-infected cells. J Infect Dis 174:1105-1108, 1996
25. Atkins MB, Robertson MJ, Gordon M, Lotze MT, M. D, Dubois JS, Ritz J, Sandler AB, Edington HD, Garzone PD, Mier JW, Canning CM, Battiato L, Tahara H, Sherman ML: Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. Clin Cancer Res 3:409-417, 1997
26. Leonard JP, Sherman ML, Fisher GL, Buchanan LJ, Larsen G, Atkins MB, Sosman JA, Dutcher JP, Vogelzang NJ, Ryan JL: Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Blood 90: 2541-8, 1997
27. Gollob JA, Schnipper CP, Orsini E, Murphy E, Daley JF, Lazo Sb, Frank DA, Neuberg D, Ritz J: Characterization of a novel subset of CD8+ T cells that expands in patients receiving interleukin-12. J Clin Invest 102:561-575, 1998
28. Levi M, ten Cate H, Bauer KA, van der Poll T, Edgington TS, Buller HR, van Deventer SJ, Hack CE, ten Cate JW, Rosenberg RD: Inhibition or endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 93:114-120, 1994
29. van Leenen D, van der Poll T, Levi M, ten Cate H, van Deventer SJ, Hack CE, Aarden LA, ten Cate JW: Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees. J Immunol 151:2318-2325, 1993
30. Decker D, Schöndorf M, Bidlingmaier F, Hirner A, von Ruecker AA: Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery 119:316-325, 1996
31. Hensler T, Hecker H, Heeg K, Heidecke CD, Bartels H, Barthlen W, Wagner H, Siewert JR, Holzmann B: Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun 65:2283-2291, 1997
32. Mossman TR, Sad S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146, 1996
33. Mureille E, Leo O: Revisiting the Th1/Th2 paradigm. Scand J Immunol 47:1-9, 1998
34. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 383:787-793, 1996
35. Petrovsky N, and Harrison LC: Diurnal rhythmicity of human cytokine production. A dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance? J Immunol 158:5163-5168, 1997
36. De Groote D, Zangerle PF, Gevaert Y, Fassotte MF, Beguin Y, Noizat-Pirenne F, Pirenne J, Gathy R, Lopez M, Dehart I, et al.: Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 4:239-248, 1992
37. Bancroft GJ: The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 5:503-510, 1993
38. Berke G: Unlocking the secrets of CTL and NK cells. Immunol Today 16:343-346, 1995
39. Smyth MJ, Trapani aJA: Granzymes: Exogenous proteinases that induce target cell apoptosis. Immunol Today 16:202-206, 1995
40. DeBlaker-Hohe DF, Yamauchi A, Yu CR, Horvath-Arcidiacuno JA, Bloom ET: IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells. Cell Immunol 165:33-43, 1995
41. Salcedo TW, Azzoni L, Wolf SF, Perussia B: Modulation of perforin and granzyme messenger RNA expression in human natural killer cells. J Immunol 151:2511-2520, 1993
42. Tripp CS, Wolf SF, Unanue ER: Interleukin-12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin-10 is a physiologic antagonist. Proc Natl Acad Sci USA 90:3725-3729, 1993
43. Carson WE, Ross ME, Baiocchi RA, Marlen MJ, Boiani N, Grabstein K, Caligiuri MA: Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-g by natural killer cells in vitro. J Clin Invest 96:2578-2582, 1995
44. Zhang T, Kawakami K, Qureshi MH, Okamura H, Kurimoto M, Saito A: Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoncal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect Immun 65:3594-3599, 1997
45. Kubin M, Kamoun M, Trinchieri G: Interleukin-12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med 180:211-222, 1994
46. Gollob JA, Li J, Kawasaki H, Daley JF, Groves C, Reinherz EL, Ritz J: Molecular interaction between CD58 and CD2 counter-receptors mediates the ability of monocytes to augment T cell activation by IL-12. J Immunol 157:1886-1893, 1996
47. Gollob JA, Ritz J: CD2-CD58 interaction and the control of T-cell interleukin-12 responsiveness. Adhesion molecules link innate and acquired immunity. Ann NY Acad Sci 795:71-81, 1996
48. Hollak CE, van Weely S, van Oers MH, Aerts JM: Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 93:1288-1292, 1994
49. Guo Y, He W, Boer AM, Wevers RA, de Bruijn AM, Groener JE, Hollak CE, Aerts JM, Galjaard H, van Diggelen OP: Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J Inher Metab Dis 18:717-722, 1995